Selkirk, NY, United States of America

Van-Duc Le

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Van-Duc Le

Introduction

Van-Duc Le is an accomplished inventor based in Selkirk, NY (US). He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of two patents to his name, his work has the potential to impact various medical conditions.

Latest Patents

Van-Duc Le's latest patents include "Polycyclic Guanine Derivatives and Use Thereof" and "Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof." The first patent relates to polycyclic guanine derivatives, compositions that include these derivatives, and methods for using them to treat pain or inflammatory diseases. The second patent focuses on novel benzodiazepine derivatives and related compounds, providing methods for their discovery and therapeutic use. These compounds aim to address conditions associated with faulty regulation of programmed cell death, autoimmunity, inflammation, and hyperproliferation.

Career Highlights

Throughout his career, Van-Duc Le has worked with notable organizations such as Merck Sharp & Dohme Corporation and the University of Michigan. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Van-Duc Le's coworkers include William Bert Geiss and Deen Tulshian. Their collaborative efforts have likely enhanced the quality and impact of his research.

Conclusion

Van-Duc Le's innovative work in the field of chemistry, particularly through his patents, showcases his dedication to advancing medical science. His contributions have the potential to lead to significant improvements in therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…